Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
about
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorderNature and Treatment of Comorbid Alcohol Problems and Post Traumatic Stress Disorder Among American Military Personnel and VeteransPosttraumatic stress disorder in adults: impact, comorbidity, risk factors, and treatmentAssessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP)Changes in comorbid conditions after prolonged exposure for PTSD: a literature reviewCombining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trialImplementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs.Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption.Pilot trial of an expressive writing intervention with HIV-positive methamphetamine-using men who have sex with men.Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.Treatment of co-occurring PTSD-AUD: effects of exposure-based and non-trauma focused psychotherapy on alcohol and trauma cue-reactivityVA Residential Provider Perceptions of Dissuading Factors to the Use of Two Evidence-Based PTSD Treatments.The effect of a yoga intervention on alcohol and drug abuse risk in veteran and civilian women with posttraumatic stress disorder.A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.A controlled examination of two coping skills for daily alcohol use and PTSD symptom severity among dually diagnosed individuals.Treatment of co-occurring anxiety disorders and substance use disorders.Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneMechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence.The problem of dropout from "gold standard" PTSD therapies.A randomized controlled trial of treatments for co-occurring substance use disorders and post-traumatic stress disorderTreatment outcomes for veterans with PTSD and substance use: Impact of specific substances and achievement of abstinence.Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD: study protocol for a randomized controlled trial.Roles for the endocannabinoid system in ethanol-motivated behavior.Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome.The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving.Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement mattersThe impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders.Characterization of comorbid PTSD in treatment-seeking alcohol dependent inpatients: Severity and personality trait differences.Treatment Engagement: Female Survivors of Intimate Partner Violence in Treatment for PTSD and Alcohol Use DisorderA Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.Improving and sustaining delivery of CPT for PTSD in mental health systems: a cluster randomized trial.At the crossroads: the intersection of substance use disorders, anxiety disorders, and posttraumatic stress disorder.Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder.Concurrent Treatment of Substance Use and PTSD.Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder.Treatment of alcohol use disorder and co-occurring PTSD.No Wrong Doors: Findings from a Critical Review of Behavioral Randomized Clinical Trials for Individuals with Co-Occurring Alcohol/Drug Problems and Posttraumatic Stress Disorder.Posttraumatic Stress Disorder and Alcohol Use Disorder: A Critical Review of Pharmacologic Treatments.
P2860
Q24185928-59164E9F-22D1-4788-B5D9-6BB4E0F07761Q26751076-0355BF3B-2971-4361-87B1-A0345CB938A6Q28085335-5919326D-F8E0-4EC6-82CA-43ECFFDFE452Q28385622-585300DE-9A79-4DEC-908E-2F4D3906FFC6Q28389179-F2761EB8-69B0-4C13-8739-4AE394F341E9Q28390909-D9E112CD-41C3-427B-8FBC-51C4F66EB1A4Q30372365-608E3C8F-6B88-466E-B9E7-D5D48DE1E88FQ33585822-D30CC40A-4362-4375-8CB3-6128938C8CC0Q33827721-00DED8CF-762F-4377-A0B5-526ACD4ECDF3Q34098366-84944165-5440-4B1E-A6EA-CEFACDBFFC8EQ34300815-028C512C-FD80-4C61-A635-FF66DFE894A7Q34323365-9AD2BFCC-CC7A-417D-B923-2D0E7AD2D722Q34329947-498E3504-A5C0-4F71-8339-FA957523FF5CQ34669057-5146FF67-E26A-4B0F-84CA-437D22A536FEQ35137449-2BC13831-A268-4D11-AA39-DF3803822154Q35166440-064501E3-2B84-4F39-8420-994987DA3975Q35619851-84683335-43D8-4760-B3E4-5DD5F163DA3DQ35652737-BE7B8CF4-CF74-418F-A024-231EA48E3695Q35659360-DDB628D6-7AE2-44DB-8E3A-38EDA554C151Q35772387-7DB8EED0-C9CC-4277-9308-FAC6C761EAFBQ36248807-FCE55D8C-DB82-4B92-A7F2-1F621B25C7EEQ36311188-8D64F3DF-26B8-447E-BFA8-E4B6B096E750Q36373102-9D30872C-E1A8-40E6-A4D4-B533E3C11CC3Q36415071-93EA8D52-DE08-4D82-9635-EADD48E97470Q36712152-AF03E951-AD00-4EAB-9D21-FDDC20C2F21BQ36788724-A0369BA3-C5B6-470F-A2B5-9B32B2FBFC93Q36900289-8B7502B9-70F6-493B-81D3-43F6E2A94CE4Q36936196-E62B2135-A76C-41AD-B839-8F78B552D0EDQ37025093-585AA6AE-0365-47E6-B6A4-D91E65D1246AQ37580733-0847A1A0-D5B4-47FE-8FE3-2D1EAE378D99Q37684184-BCDB4CD7-4AF8-4921-BEE7-BAA8B9942D2CQ38249950-B1B8CB1F-0ABF-40D9-8285-F2D244FDFCE7Q38370133-74D9C913-1177-422D-B41A-B13CED81E107Q38798292-D8F4A6A2-AF01-4785-BD4E-6EE653B7AE46Q38859526-5CEA2866-2BB0-4F53-A63C-545FC6DD8C2FQ38916400-77600CA3-A678-48E9-B97E-C12161FCF9CBQ38982604-6E81D072-6287-4B51-9992-6C6389F251EAQ39051759-39DCC799-9BAF-43FD-BF24-E033FCF2012FQ39068266-D7A6B3D9-D087-4325-8D0A-49DF7D7453AEQ39094898-0136268A-FAB4-4C78-8741-074ADB98D5FF
P2860
Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Concurrent naltrexone and prol ...... : a randomized clinical trial.
@en
type
label
Concurrent naltrexone and prol ...... : a randomized clinical trial.
@en
prefLabel
Concurrent naltrexone and prol ...... : a randomized clinical trial.
@en
P2093
P356
P1476
Concurrent naltrexone and prol ...... : a randomized clinical trial.
@en
P2093
Carmen P McLean
Charles P O'Brien
David A Yusko
David Oslin
David S Riggs
Donald A Bux
Edna B Foa
Joseph Volpicelli
Michael K Suvak
Patricia Imms
P304
P356
10.1001/JAMA.2013.8268
P407
P577
2013-08-01T00:00:00Z